Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma

Published:2019-10 Issue:10 Volume:41 Page:1956-1971
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kavati Abhishek,Zhdanava Maryia,Ortiz Benjamin,Lecocq Jason,Schiffman Bradd,Pilon Dominic,Ho Harriet,Lefebvre Patrick,Stone Brian

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. Asthma,2018

2. Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey;Murphy;Allergy Asthma Proc,2012

3. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS);Stanford;J Asthma,2010

4. Xolair [prescribing Information],2016

5. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma;Frontiers in Immunology;2024-04-19

2. Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment;Immunopharmacology and Immunotoxicology;2023-12-27

3. Necesidades no cubiertas en asma alérgica grave;Open Respiratory Archives;2023-10

4. Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review;Antioxidants;2023-02-07

5. Role of clinical biomarkers in predicting the effectiveness of omalizumab;Therapeutic Advances in Respiratory Disease;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3